Trident Lifeline Ltd. manufactures and markets pharmaceutical products. The company is headquartered in Surat, Gujarat. The company went IPO on 2022-10-10. The firm is also engaged in distribution of pharmaceutical products through a third party distribution network. The company offers a range of pharmaceutical formulations and products manufactured on contract manufacturing under loan license. The company deals in capsules, tablets, liquid ointment, gel, ice gel, mouthwash, paste, solution, suspension, dry powders and toothpaste. Its product portfolio includes a range of drugs like Anti-Bacterial, Anti Diarrheal, Anti-Fungal, Anti-Malarial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozoal, Anti Histamine, Anti-Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral Nutraceutical and Non-steroidal anti-inflammatory drug (NSAIDS). Its product portfolio consists of approximately 832 products. The company operates in India, as well as African, Latin American and East Indian countries.
Loading chart…
This company hasn't held an earnings call in the last six months, so there's no recent commentary from management. Our deep dives are built on what management actually said, so we haven't prepared one.